BAX and lymphoma: Interestingly, while 5’azacytidine treatment could increase Bax transcript levels in the other drug-resistant BAX KO cell lines tested, it could not restore sensitivity of any of these drug-resistant lymphoma cells to S63845, confirming that a functional BAX protein was not being made in these cells (Fig. 5D).